The biopharma Neurimmune and the venture capital fund TVM Life Science Ventures VII announced they have created a Swiss company called AL-S Pharma AG to develop a new therapy for the treatment of amyotrophic lateral sclerosis (ALS). AL-S Pharma AG is a special purpose company formed to develop one compound — AP-101…

The nutritional status of patients with amyotrophic lateral sclerosis (ALS) tends to decrease with disease progression, which further increases their fragility and low energy. A new study shows that nutritional counseling may increase food consumption in ALS patients and delay the loss of muscle and fat. The study, “Assessment…

Researchers report that the co-occurrence of amyotrophic lateral sclerosis (ALS) and the autoimmune disease myasthenia gravis is far greater than expected, raising the possibility that the two conditions share underlying disease-causing events. But to understand if that is the case, researchers need to invest in studies of similarities in the…

This emotional ABC News video shares how amyotrophic lateral sclerosis (ALS) has impacted former NFL star Steve Gleason’s life. Cristiano Ronaldo invites former soccer player with ALS to the Bernabeu stadium. The 39-year-old New Orleans Saints hero created a video blog about his journey with ALS, documenting the progression…

How the TBK1 protein, the cell’s “clearing machinery,” contributes to the development of amyotrophic lateral sclerosis (ALS) was the focus of a recent review study. The review, “Association Of Mutations In TBK1 With Sporadic And Familial Amyotrophic Lateral Sclerosis And Frontotemporal Dementia,” published in the journal JAMA Neurology, was…

The Smithsonian’s National Museum of American History opened its long-term exhibition “Giving in America” on Nov. 29 to display the history of philanthropy’s role in shaping the United States. The collection includes one of the first buckets that tied the Ice Bucket Challenge to amyotrophic lateral sclerosis…

ALS League Belgium, a patient organization helping the families of people with amyotrophic lateral sclerosis (ALS), raised €302,000 (euro) to stimulate and fund research into the life-threatening nerve muscle disease. Three projects have been selected for support by ALS League Belgium this year, and details will be updated…

Researchers have found neuronal progenitor cells (immature cells that can become neurons) in the meninges, a three-layer structure enclosing the brain that protects the nervous system, according to a new study. This finding may lead to the development of new stem cell therapies for brain damage and neurodegenerative disorders such as…

Recent research demonstrates that patients with amyotrophic lateral sclerosis (ALS) have a higher risk of developing depression, both immediately before and after being diagnosed with ALS. While the study, “Depression in amyotrophic lateral sclerosis,” which appeared in the journal Neurology, could not state exactly how or…

Amyotrophic lateral sclerosis (ALS) is a progressive disease that attacks the motor neurons in the nervous system and causes acute disability. It is also known as Lou Gehrig’s disease, after the American baseball player who was famously diagnosed with the condition. We’ve compiled a list of some of the most…